Martin Babler Alumis Inc. (ALMS) insider trading activity

ALMS Quotes by TradingView

Martin Babler Transaction History

Date Transaction Value Shares Traded Form
Jul 01 2024
SELL
Sale (or disposition) back to the issuer
-
90,804
Jul 01 2024
BUY
Grant, award, or other acquisition
-
90,804

Also insider at

NLTX
Neoleukin Therapeutics, Inc. Healthcare
Director
PRLD
Prelude Therapeutics Inc Healthcare
ETNB
89bio, Inc. Healthcare
MB

Martin Babler

President, CEO and Chairman
Seattle, WA

Track Institutional and Insider Activities on ALMS

Follow ALUMIS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALMS shares.

Notify only if

Insider Trading

Get notified when an Alumis Inc. insider buys or sells ALMS shares.

Notify only if

News

Receive news related to ALUMIS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALMS